A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial-Reference-Cited by-同舟云学术

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial

Published:2018-04 Issue: Volume:96 Page:35-46
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Donovan Jenny L.,Young Grace J.,Walsh Eleanor I.,Metcalfe Chris,Lane J. Athene,Martin Richard M.,Tazewell Marta K.,Davis Michael,Peters Tim J.,Turner Emma L.,Mills Nicola,Khazragui Hanan,Khera Tarnjit K.,Neal David E.,Hamdy Freddie C.,Bollina Prasad,Catto James,Doble Andrew,Doherty Alan,Gillatt David,Gnanapragasam Vincent,Holding Peter,Hughes Owen,Kockelbergh Roger,Kynaston Howard,Mason Malcolm,Oxley Jon,Paul Alan,Paez Edgar,Rosario Derek J.,Rowe Edward,Staffurth John

Publisher

Elsevier BV

Subject

Epidemiology

Reference42 articles.

1. External validity of randomised controlled trials: “to whom do the results of this trial apply?”;Rothwell;Lancet,2005

2. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results;Kennedy-Martin;Trials,2015

3. How to assess the external validity of therapeutic trials: a conceptual approach;Dekkers;Int J Epidemiol,2010

4. Commentary: external validity of results of randomized trials: disentangling a complex concept;Rothwell;Int J Epidemiol,2010

5. Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology;Green;Eval Health Prof,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of pelvic-fascia sparing robotic-assisted radical prostatectomy versus standard technique: Superior urinary function and quality of life without compromising oncologic efficacy in a single-surgeon series;Urologic Oncology: Seminars and Original Investigations;2024-03

2. Reply to Greg Shaw, John D. Kelly, and Monique J. Roobol’s Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547–58;European Urology;2023-11

3. Efficacy and Effectiveness: Bridging the Gap Between Clinical Trials and Real-world Practice;European Urology Oncology;2023-07

4. The impact of treatment preferences: A narrative review;Journal of Evaluation in Clinical Practice;2023-05-04

5. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer;New England Journal of Medicine;2023-04-27